Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0O0DF
|
||||
Former ID |
DIB004410
|
||||
Drug Name |
Lirequinil
|
||||
Synonyms |
Ro-41-3696
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Anxiety disorder [ICD9: 300, 311; ICD10:F32, F40-F42] | Discontinued in Phase 2 | [545048] | ||
Company |
Roche Holding AG
|
||||
Structure |
Download2D MOL |
||||
Formula |
C26H25ClN2O3
|
||||
Canonical SMILES |
c1(c2n(c(=O)c(c1)c1ccccc1)CCc1c2cc(cc1)Cl)C(=O)N1C[C@H]<br />(CC1)OCC
|
||||
CAS Number |
CAS 143943-73-1
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Peripheral-type benzodiazepine receptor | Target Info | Agonist | [534064] | |
KEGG Pathway | Neuroactive ligand-receptor interaction | ||||
HTLV-I infection | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.